Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Thyroid transcription factor-1 (TTF-1) expression and the efficacy of combination therapy with immune checkpoint inhibitors and cytotoxic chemotherapy in non-squamous non-small cell lung cancer.
Iso H, Hisakane K, Mikami E, Suzuki T, Matsuki S, Atsumi K, Nagata K, Seike M, Hirose T. Iso H, et al. Among authors: matsuki s. Transl Lung Cancer Res. 2023 Sep 28;12(9):1850-1861. doi: 10.21037/tlcr-23-331. Epub 2023 Sep 13. Transl Lung Cancer Res. 2023. PMID: 37854151 Free PMC article.
IgA vasculitis induced by carboplatin + nab-paclitaxel + pembrolizumab in a patient with advanced lung squamous cell carcinoma: a case report.
Terashima Y, Matsumoto M, Ozaki S, Nakagawa M, Nakagome S, Terasaki Y, Iida H, Mitsugi R, Kuramochi E, Okada N, Inoue T, Matsuki S, Kitagawa S, Fukuizumi A, Onda N, Takeuchi S, Miyanaga A, Kasahara K, Seike M. Terashima Y, et al. Among authors: matsuki s. Front Immunol. 2024 Aug 14;15:1370972. doi: 10.3389/fimmu.2024.1370972. eCollection 2024. Front Immunol. 2024. PMID: 39206190 Free PMC article.
Pharmacokinetics, safety, and tolerability of the novel tetrameric gadolinium-based MRI contrast agent gadoquatrane in healthy Chinese and Japanese men: Two randomized dose-escalation studies including concentration-QTc modeling.
He X, Matsuki S, Li K, Sui Y, Matsuno K, Ren M, Sutter G, Hofmann BM. He X, et al. Among authors: matsuki s. Eur J Pharm Sci. 2024 May 1;196:106749. doi: 10.1016/j.ejps.2024.106749. Epub 2024 Mar 16. Eur J Pharm Sci. 2024. PMID: 38499113 Free article.
190 results